Abstract
The relationship between the drug industry and the medical profession has become corrupt, resulting in a loss of public confidence. Causes are conventional drug promotion tactics and industry support of postgraduate medical education and research. Twelve of the fourteen members of the committee that monitors the Association of the British Pharmaceutical Industry's code of practice are from industry. An increase of non-industrial members and extended powers of expulsion or suspension of offending firms are advocated. Research collaboration between the medical profession and the pharmaceutical industry is considered to be essential; however, trials and investigations involving volunteers or patients should be overseen by ethics committees. Ultimately, responsibility for improving the relationship lies mainly with the medical profession.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
